Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02586558
Other study ID # INCH-681
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date December 13, 2017
Est. completion date August 15, 2019

Study information

Verified date August 2019
Source McMaster University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Colic, or inconsolable crying and fussing, affects around 20% of babies who are 3 months of age or younger. To date, there are no known treatments that have been found to help reduce colic and its symptoms in babies. The investigators would like to see whether a baby formula that contains a prebiotic will lead to the same improvements in babies with colic. The investigators will test this by giving some babies a formula with the prebiotic and other babies a placebo formula.


Recruitment information / eligibility

Status Terminated
Enrollment 1
Est. completion date August 15, 2019
Est. primary completion date August 15, 2019
Accepts healthy volunteers No
Gender All
Age group N/A to 8 Weeks
Eligibility Inclusion Criteria:

- Healthy, term infant from a singleton birth (=>37 weeks gestational age); formula fed; primary caregiver able to read and write in English; current colicky behaviour

Exclusion Criteria:

- Infants with known genetic syndromes; birth weight (<2500g); use of proton pump inhibitors; use of antibiotics in previous week; use of nutritional colic remedies; use of probiotics; maternal medical history of diabetes (excluding gestational diabetes), tuberculosis, or any perinatal infection while pregnant with child enrolled in study; presence of blood in infant stool sample; possible cow milk protein allergy

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Experimental Infant formula
Ready-to-feed infant formula to be fed ad libitum
Reference group
Ready-to-feed infant formula to be fed ad libitum

Locations

Country Name City State
Canada David Braley Health Sciences Centre Hamilton Ontario

Sponsors (2)

Lead Sponsor Collaborator
McMaster University Abbott Nutrition

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Infant crying and fussing behaviour As assessed by the Barr Baby Behavior Diary 6 weeks
Secondary Infant crying and fussing behaviour As assessed by actigraphy and accelerometry 6 weeks
Secondary Stool Microbiota 6 weeks
Secondary Stool calprotectin 6 weeks
Secondary Parent satisfaction As assessed by parent survey 6 weeks
Secondary Infant behaviour As assessed by parent survey 6 weeks
Secondary Infant feeding patterns As assessed by parent survey 6 weeks
Secondary Infant stool patterns As assessed by parent survey 6 weeks
Secondary Postnatal depression As assessed by parent survey 6 weeks
See also
  Status Clinical Trial Phase
Completed NCT01849991 - Safety and Effect of L. Reuteri on Biomarkers of Inflammation in Healthy Infants With Colic Phase 1
Completed NCT01279265 - Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Colic N/A
Completed NCT00177086 - Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi Phase 3
Not yet recruiting NCT02577133 - Prevention of Colic With the Probiotic Lactobacillus Reuteri Phase 2/Phase 3
Recruiting NCT01715220 - Treatment of Suspected Cholelithiasis With Nitroglycerin Phase 2
Completed NCT00922727 - Safety of Lactobacillus Reuteri (L. Reuteri) in Healthy Adults Phase 1
Completed NCT02865564 - Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics N/A
Completed NCT01997593 - Peritoneal Ropivacaine Infiltration on Postoperative Pain in Children Affected Phase 2
Completed NCT01541046 - Lactobacillus Reuteri DSM 17938 Versus Placebo in the Treatment of Infantile Colic Phase 2
Completed NCT00929292 - Safety and Tolerance Study of Alpha-Lactalbumin Enriched and Probiotic-Supplemented Infant Formula in Infants With Colic Phase 3
Terminated NCT05554991 - Human Milk Oligosaccharide (HMO) Supplementation in Colic Management N/A
Recruiting NCT01067027 - Control of Colic in Infants by Dietary Supplementation With the Probiotic Lactobacillus Reuteri Phase 4
Recruiting NCT04983069 - Neonatal Outcome of Children With Antenatal Colic Hyperechogenicity
Recruiting NCT05685030 - Probiotics Strains for Infant Colic Phase 2
Withdrawn NCT05198700 - The Effect of Probiotics on Symptoms of Infantile Colic Phase 2
Completed NCT01532518 - Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance Phase 2
Completed NCT00796523 - An Intervention to Decrease Infant Crying N/A
Completed NCT05052476 - First Line Dose-efficacy Study of Bactecal® D Liquid for Infant Colic N/A
Completed NCT02242292 - Study to Evaluate Efficacy and Safety of Oral Doses of Hyoscine Butylbromide for the Treatment of Occasional Abdominal Pain, Cramping, and Discomfort Phase 2
Terminated NCT00139646 - Parecoxib in Renal Colic Phase 3